Intercept Pharmaceuticals Alternatives & Competitors
12 companies similar to Intercept Pharmaceuticals — Our mission is to build a healthier tomorrow for patients with rare and serious...
Companies similar to Intercept Pharmaceuticals
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
Newark, United States
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
HighTide Therapeutics
East Meets West—The Quest for Cure
Shenzhen, China
AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
Menlo Park, United States
Track all Intercept Pharmaceuticals competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...
Watertown, United States
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...
Bozeman, United States
Atom Therapeutics
Atom Therapeutics Co., Ltd
Suzhou, China
Concortis Biosystems Corp
Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduc...
San Diego, United States
Xanthus Pharmaceuticals
Innovative treatments for cancer and autoimmune disorders through pioneering small-molecul...
Cyrus Therapeutics
Drugging the undruggable targets
Seoul, Korea South
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
About Intercept Pharmaceuticals
Intercept Pharmaceuticals, founded in 2002, is a biopharmaceutical company focused on developing novel therapeutics to treat rare and serious liver diseases such as primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). The company's last investment of $447.70M in Post-IPO Debt was made on 30...
Biopharmaceutical, Liver Diseases, Rare Diseases, Drug Development, Therapeutics, Chronic Autoimmune Liver Diseases, Small Molecule Drugs, Fibrotic Diseases, Metabolic Diseases, Bile Acid Receptors, Chronic Liver Diseases, Non-viral Liver Diseases, Innovation
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Intercept Pharmaceuticals and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Intercept Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 1 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
